MLSS vs. NYXH, SMTI, ZIMV, STIM, TCMD, SNWV, NVRO, DRTS, SKIN, and SGHT
Should you be buying Milestone Scientific stock or one of its competitors? The main competitors of Milestone Scientific include Nyxoah (NYXH), Sanara MedTech (SMTI), ZimVie (ZIMV), Neuronetics (STIM), Tactile Systems Technology (TCMD), SANUWAVE Health (SNWV), Nevro (NVRO), Alpha Tau Medical (DRTS), Beauty Health (SKIN), and Sight Sciences (SGHT). These companies are all part of the "medical equipment" industry.
Milestone Scientific vs. Its Competitors
Nyxoah (NASDAQ:NYXH) and Milestone Scientific (NYSE:MLSS) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their earnings, risk, analyst recommendations, profitability, institutional ownership, dividends, community ranking, media sentiment and valuation.
Nyxoah received 40 more outperform votes than Milestone Scientific when rated by MarketBeat users. Likewise, 73.68% of users gave Nyxoah an outperform vote while only 2.17% of users gave Milestone Scientific an outperform vote.
Milestone Scientific has a net margin of -52.01% compared to Nyxoah's net margin of -1,043.93%. Nyxoah's return on equity of -51.68% beat Milestone Scientific's return on equity.
Nyxoah currently has a consensus target price of $14.50, suggesting a potential upside of 89.79%. Milestone Scientific has a consensus target price of $1.25, suggesting a potential upside of 39.84%. Given Nyxoah's higher probable upside, equities analysts plainly believe Nyxoah is more favorable than Milestone Scientific.
In the previous week, Nyxoah had 1 more articles in the media than Milestone Scientific. MarketBeat recorded 7 mentions for Nyxoah and 6 mentions for Milestone Scientific. Nyxoah's average media sentiment score of 0.79 beat Milestone Scientific's score of -0.04 indicating that Nyxoah is being referred to more favorably in the media.
Milestone Scientific has higher revenue and earnings than Nyxoah. Milestone Scientific is trading at a lower price-to-earnings ratio than Nyxoah, indicating that it is currently the more affordable of the two stocks.
5.8% of Milestone Scientific shares are held by institutional investors. 17.1% of Nyxoah shares are held by company insiders. Comparatively, 24.8% of Milestone Scientific shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
Nyxoah has a beta of 1.65, suggesting that its stock price is 65% more volatile than the S&P 500. Comparatively, Milestone Scientific has a beta of 0.9, suggesting that its stock price is 10% less volatile than the S&P 500.
Summary
Nyxoah beats Milestone Scientific on 11 of the 17 factors compared between the two stocks.
Get Milestone Scientific News Delivered to You Automatically
Sign up to receive the latest news and ratings for MLSS and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding MLSS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Milestone Scientific Competitors List
Related Companies and Tools
This page (NYSE:MLSS) was last updated on 6/12/2025 by MarketBeat.com Staff
